Activity of rat UGT1A1 towards benzo[a]pyrene phenols and dihydrodiols

被引:3
|
作者
Webb, L [1 ]
Miles, K [1 ]
Kessler, F [1 ]
Ritter, JK [1 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
UDP-glucuronosyltransferase; benzo[a]pyrene; glucuronidation; environmental carcinogenesis;
D O I
10.1016/j.etap.2005.07.018
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Four UDP-glucuronosyltransferases from the rat UGT1A family were tested for activity towards benzo[a]pyrene pyenols and dihydrodiols. UGTIA1 and UGTI1A7 were found to be broadly active towards BaP metabolites. Antisera recognizing rat UGT1A1 and UGT1A7 were used to assess UGT levels in relation to UGT activity towards benzo[a]pyrene-7.8-dihydrodiol (BPD). The rank BPD UGT activities were liver=intestine kidney, whereas UGT1A1 was highest in liver and UGT1A7 was highest in intestine. Phenobarbital, an inducer of hepatic UGT1A1, only slightly increased BPD UGT activity, whereas UGT1A7 inducers more potently increased the activity. Inhibition studies using the differential UGTIAI inhibitor, bilirubin, suggest that UGT1A1 is not a major contributor to the constitutive BPD glucuronidating activity of control rat liver microsomes. These data suggest that multiple UGT1A enzymes contribute to glucuronidation of BPD and other BaP metabolites, and that their relative contributions depend on tissue- and environmental-specific factors. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 50 条
  • [1] MONOGLUCURONIDE AND DIGLUCURONIDE FORMATION FROM CHRYSENE AND BENZO(A)PYRENE PHENOLS BY 3-METHYLCHOLANTHRENE-INDUCIBLE PHENOL UDP-GLUCURONOSYLTRANSFERASE (UGT1A1)
    BOCK, KW
    GSCHAIDMEIER, H
    SEIDEL, A
    BAIRD, S
    BURCHELL, B
    MOLECULAR PHARMACOLOGY, 1992, 42 (04) : 613 - 618
  • [2] ENZYMATIC CONVERSION OF BENZO(A)PYRENE PHENOLS, DIHYDRODIOLS AND QUINONES TO SULFATE CONJUGATES
    NEMOTO, N
    TAKAYAMA, S
    GELBOIN, HV
    BIOCHEMICAL PHARMACOLOGY, 1977, 26 (19) : 1825 - 1829
  • [3] Towards UGT1A1 guided irinotecan dosing
    Hicks, J. Kevin
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 (09) : 980 - 981
  • [4] Towards UGT1A1 guided irinotecan dosing
    J. Kevin Hicks
    European Journal of Human Genetics, 2023, 31 : 980 - 981
  • [5] Evolution of the activity of UGT1A1 throughout the development and adult life in a rat
    Bustamante, N
    Cantarino, MH
    Arahuetes, RM
    Cubero, FJ
    Ortiz, A
    LIFE SCIENCES, 2006, 78 (15) : 1688 - 1695
  • [6] Estimating the Differences of UGT1A1 Activity in Recombinant UGT1A1 Enzyme, Human Liver Microsomes and Rat Liver Microsome Incubation Systems in Vitro
    Wang, Qi
    Dai, Zhong
    Wen, Binyu
    Ma, Shuangcheng
    Zhang, Yujie
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (12) : 1910 - 1917
  • [7] Differential modulation of human UGT1A1 activity
    Williams, JA
    Ring, BJ
    Cantrell, VE
    Campanale, K
    Jones, DR
    Hall, SD
    Wrighton, SA
    DRUG METABOLISM REVIEWS, 2002, 34 : 196 - 196
  • [8] UGT1A1*6 and UGT1A1*27 for individualized irinotecan chemotherapy
    Ando, Yuichi
    Fujita, Ken-ichi
    Sasaki, Yasutsuna
    Hasegawa, Yoshinori
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2007, 9 (03) : 258 - 262
  • [9] Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
    Amandito, Radhian
    Rohsiswatmo, Rinawati
    Carolina, Erica
    Maulida, Rizka
    Kresnawati, Windhi
    Malik, Amarila
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [10] Commentary: Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
    Heydari, Mohammad Reza
    Fardaei, Majid
    FRONTIERS IN PEDIATRICS, 2020, 7